AAAAAA

   
Results: 1-5 |
Results: 5

Authors: HALFON P OUZAN D KHIRI H FERYN JM DESMORAT H BOURLIERE M BOYER N FONTANGES T MATHIEUCHANDELIER C JACQUES JP BAESJOUR S ROUHIER D LOUVET H HANSLIK B BEORCHIA S ANTONI M BRUNERIE M CORCOS D RICHARDMOLARD B PIERRUGUES R CAUCANAS J JOUANOLLE H
Citation: P. Halfon et al., SEROTYPING AND GENOTYPING OF HEPATITIS-C VIRUS (HCV) STRAINS IN CHRONIC HCV INFECTION, Journal of medical virology, 52(4), 1997, pp. 391-395

Authors: DURAND DV LECOMTE C CATHEBRAS P ROUSSET H GODEAU P BOUCHER JP SIMON G DUPOND JL MIGUET JP DEWAZIERES B CHRAIBI A DABADIE H PACCALIN J BOCQUET B BRUHIERE J DEBAT P PHILIPPE P DEVAUX P ADAM G HILLON P MASSOT P CANCE P WATON M LEVRAT R PASQUIER J TREPO C FALCONNET M PAUCHARD J GUTKNECHT J JANBON C BARRIER JH COTTIN S GUILLON J MAGADURJOLY G ALLARD C DESSAUW P BARBIER JP BLEIBEL JM BUGE A CABANE J HAAS C HUGUIER M PIETTE AM POISSON M WECHSLER B GROSBOIS B AUDIGIER JC MALLET H ROUHIER D RONDOT P
Citation: Dv. Durand et al., WHIPPLE-DISEASE - CLINICAL REVIEW OF 52 CASES, Medicine, 76(3), 1997, pp. 170-184

Authors: HOUCKE P FORESTIER S GOLDFAIN D GUYOT P HELBERT T LAURENT J REY JF ROUHIER D CASSIGNEUL J MARCHETTI B PAPAZIAN A
Citation: P. Houcke et al., 15 MG LANSOPRAZOLE DAILY OR 30 MG LANSOPRAZOLE EVERY OTHER DAY IN LONG-TERM TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, Gut, 41, 1997, pp. 202-202

Authors: HOUCKE P FORESTIER S GOLDFAIN D GUYOT P HELBERT T LAURENT J REY JF ROUHIER D CASSIGNEUL J MARCHETTI B PAPAZIAN A
Citation: P. Houcke et al., 15 MG LANSOPRAZOLE DAILY OR 30 MG LANSOPRAZOLE EVERY OTHER DAY IN LONG-TERM TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, Gastroenterology, 112(4), 1997, pp. 152-152

Authors: OUZAN D DESMORAT H BOURLIERE M BALDINI E BOYER N FONTANGES T MATHIEUCHANDELIER C JACQUES JP BAESJOU S ROUHIER D LOUVET H HANSLIK B BEORCHIA S ANTONI M BRUNERIE M CORCOS D RICHARDMOLARD B PIERRUGUES R CAUCANAS J JOUANOLLE H DUMANOIR C LANGLOIS C LEMONNIER C KHIRI H BRICHETTI A HALFON P
Citation: D. Ouzan et al., SUSTAINED RESPONSE TO INTERFERON-ALFA 2B IS AFFECTED BY DOSE AND DURATION OF THERAPY - PRELIMINARY-RESULTS OF A FRENCH MULTICENTER RANDOMIZED TRIAL, Hepatology, 24(4), 1996, pp. 1727-1727
Risultati: 1-5 |